Raouf Seyam1, Mahmoud I Khalil2, Mohamed H Kamel2, Waleed M Altaweel1, Rodney Davis2, Nabil K Bissada3. 1. Department of Urology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. 2. Department of Urology, University of Arkansas for Medical Sciences, Little Rock, AR, USA. 3. Department of Urology, Baylor College of Medicine and Michael E. De Bakey VA Medical Center, Houston, TX, USA. bissadan@hotmail.com.
Abstract
PURPOSE: Organ-sparing surgery (OSS) for the kidney and adrenals has emerged as the need for preservation of function is paramount in patients with poor functional reserve. As reports increasingly showed that oncological outcomes were equivalent to radical excision, elective OSS became a viable alternative in patients with otherwise normal reserve. In this review, we summarize the current knowledge of OSS for adrenal and renal tumors. MATERIALS AND METHODS: PubMed, Web of Science and Cochrane Library Central Search were searched for recently published articles up to December 2017. The following keywords were used; "partial adrenalectomy", "adrenal sparing", "partial nephrectomy", "nephron sparing", "kidney/renal cancer". RESULTS: Partial adrenalectomy became an attractive alternative to total adrenalectomy avoiding adrenal insufficiency. Both minimally invasive surgery and ablative techniques were increasingly reported for adrenal OSS with adequate residual adrenal function and excellent oncological outcome. Radical nephrectomy remained for many years as the gold standard of treatment for organ-confined renal cell carcinoma. As the need to reduce the impact on renal function, more conservative approaches were utilized. Soon, the non-inferiority of nephron-sparing surgery to that of radical excision became evident and elective partial nephrectomy was gaining ground as the standard of care for small renal masses in patients with normal contralateral kidneys. CONCLUSIONS: Herein, we present a comprehensive review of the current status of OSS in renal and adrenal tumors.
PURPOSE: Organ-sparing surgery (OSS) for the kidney and adrenals has emerged as the need for preservation of function is paramount in patients with poor functional reserve. As reports increasingly showed that oncological outcomes were equivalent to radical excision, elective OSS became a viable alternative in patients with otherwise normal reserve. In this review, we summarize the current knowledge of OSS for adrenal and renal tumors. MATERIALS AND METHODS: PubMed, Web of Science and Cochrane Library Central Search were searched for recently published articles up to December 2017. The following keywords were used; "partial adrenalectomy", "adrenal sparing", "partial nephrectomy", "nephron sparing", "kidney/renal cancer". RESULTS: Partial adrenalectomy became an attractive alternative to total adrenalectomy avoiding adrenal insufficiency. Both minimally invasive surgery and ablative techniques were increasingly reported for adrenal OSS with adequate residual adrenal function and excellent oncological outcome. Radical nephrectomy remained for many years as the gold standard of treatment for organ-confined renal cell carcinoma. As the need to reduce the impact on renal function, more conservative approaches were utilized. Soon, the non-inferiority of nephron-sparing surgery to that of radical excision became evident and elective partial nephrectomy was gaining ground as the standard of care for small renal masses in patients with normal contralateral kidneys. CONCLUSIONS: Herein, we present a comprehensive review of the current status of OSS in renal and adrenal tumors.
Entities:
Keywords:
Nephron sparing; Organ sparing; Partial adrenalectomy; Partial nephrectomy
Authors: Hendrik Van Poppel; Luigi Da Pozzo; Walter Albrecht; Vsevolod Matveev; Aldo Bono; Andrzej Borkowski; Marc Colombel; Laurence Klotz; Eila Skinner; Thomas Keane; Sandrine Marreaud; Sandra Collette; Richard Sylvester Journal: Eur Urol Date: 2010-12-22 Impact factor: 20.096
Authors: Michael A Blake; Mannudeep K Kalra; Ann T Sweeney; Brian C Lucey; Michael M Maher; Dushyant V Sahani; Elkan F Halpern; Peter R Mueller; Peter F Hahn; Giles W Boland Journal: Radiology Date: 2005-12-21 Impact factor: 11.105
Authors: Hwang Gyun Jeon; In Hyuck Gong; Jin Ho Hwang; Don Kyung Choi; Seung Ryeol Lee; Dong Soo Park Journal: BJU Int Date: 2011-08-25 Impact factor: 5.588
Authors: Christopher J Weight; Benjamin T Larson; Amr F Fergany; Tianming Gao; Brian R Lane; Steven C Campbell; Jihad H Kaouk; Eric A Klein; Andrew C Novick Journal: J Urol Date: 2010-02-19 Impact factor: 7.450
Authors: Michael A Liss; Robert DeConde; Dominique Caovan; Joseph Hofler; Michael Gabe; Kerrin L Palazzi; Nishant D Patel; Hak J Lee; Trey Ideker; Hendrik Van Poppel; David Karow; Michael Aertsen; Giovanna Casola; Ithaar H Derweesh Journal: J Endourol Date: 2015-09-25 Impact factor: 2.942
Authors: Martin Marszalek; Herbert Meixl; Marko Polajnar; Michael Rauchenwald; Klaus Jeschke; Stephan Madersbacher Journal: Eur Urol Date: 2009-02-20 Impact factor: 20.096
Authors: N Roukounakis; S Dimas; I Kafetzis; S Bethanis; N Gatsulis; H Kostas; V Kyriakou; S Michas Journal: JSLS Date: 2007 Apr-Jun Impact factor: 2.172
Authors: Pier Francesco Alesina; Polina Knyazeva; Jakob Hinrichs; Martin K Walz Journal: Front Endocrinol (Lausanne) Date: 2022-03-28 Impact factor: 5.555